💊 Sanofi works on RNA expression; Lilly backs CRO funding; Mitsubishi gets into gene editing
AZ's billion-dollar oncology play
Hello and welcome back to The Kable. Lots of dealmaking and investing and acquiring and partnering today.
Also in today’s Kable: CureVac sues BioNTech; CEPI releases more funds; Oman mulls tart regulations for sweet drinks; Uruguay courts want to know ingredients in Pfizer’s Covid jab; Peru asks for masks; Novartis wants cardiac health-tech to emerge; A…